General Information
Revision date
2020-11-05
Product name
Histamine Assay Kit (Bottle 2)
Manufacturer Name
Megazyme
Icons in SDS
Company Information
company name
Megazyme
e-mail address of the competent person responsible for the Safety Data Sheet
cs@megazyme.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H302+H312+H332, H312, H332, H351
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
CLP CLASSIFICATION
Acute toxicity (oral), Category 4 H302 Acute toxicity (dermal), Category 4 H312 Acute toxicity (inhalation:dust,mist) H332 Category 4 Carcinogenicity, Category 2 H351
Hazard statements
see section 16 : H302+H312+H332 - Harmful if swallowed, in contact with skin or if inhaled H351 - Suspected of causing cancer.
Adverse physicochemical, human health and environmental effects
To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice.
2.2 Label elements
Labelling according to Regulation (EC) No. 1272/2008 [CLP] Extra labelling to displayExtra classification(s) to display
Hazard pictograms
GHS07 GHS08 GHS08
Signal word
Warning
Hazardous Ingredients
2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium chloride, INT; 1-Methoxy-5- methylphenazinium methyl sulfate : 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium chloride, INT; 1-Methoxy-5- methylphenazinium methyl sulfate
Precautionary statements
P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash hands, forearms and face thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P271 - Use only outdoors or in a well-ventilated area. Labelling according to: exemption for inner packaging where the contents do not exceed 10ml
2.3 Other hazards
No additional information available
